In June, an inaugural golf tournament being held by the Knoxville Fire Fighters Association will be raising funds to help two ...

The CHMP recommends conditional marketing authorization for Duvyzat to treat Duchenne muscular dystrophy in patients aged 6 ...

A new study led by researchers at the Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...

The 25th anniversary celebration of the Wings Over Wall Street benefit will recognize ALS researchers and advocates.

Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...

Building on its 75-year legacy of progress, MDA is reinforcing its commitment to the ALS community by driving momentum for ...

In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

The purpose of this report is to re-evaluate such a therapeutic program in muscular dystrophy when the drugs are used singly, in combination and with or without exercise. Objective serial ...

Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a ...

Multidisciplinary coordination across prescribing teams, nursing, laboratory medicine, finance, and infusion centers is ...

Researchers from University College London (UCL) are aiming to develop potential treatments for congenital muscular dystrophy ...

Muscular Dystrophy Foundation of South Africa donates three motorised wheelchairs to learners at West Rand School.